SCHEMBL7947342

SCHEMBL7947342

c1ccc(Oc2ccc(N3CCN(c4ccncc4)CC3)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.68
HRH1 P35367 4/20 0.68
HRH2 P25021 2/20 0.68
LTA4H P09960 1/20 0.62
CHKA P35790 1/20 0.52
ALDH1A1 P00352 2/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HIF1A Q16665 1/20 0.49
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
ADRB2 P07550 1/20 0.47
NCF1 P14598 1/20 0.47
PLD1 Q13393 1/20 0.47
HPGD P15428 1/20 0.47
KHK P50053 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18590696 0.82 CHKA (0.67) HRH3HRH1HRH2CHKACYP2D6
SCHEMBL16439234 0.81 HRH1 (0.55) HRH3HRH1HRH2CHKAALDH1A1
SCHEMBL2784743 0.81 LTA4H (0.70) HRH3HRH1HRH2LTA4HALDH1A1
SCHEMBL7954928 0.80 HRH1 (0.61) HRH3HRH1HRH2LTA4HCHKA
SCHEMBL4671620 0.80 LTA4H (0.64) HRH3HRH1HRH2LTA4HALDH1A1
SCHEMBL4997726 0.80 HRH1 (0.51) HRH3HRH1HRH2LTA4HALDH1A1
SCHEMBL24177916 0.79 LTA4H (0.68) HRH3HRH1HRH2LTA4HALDH1A1
SCHEMBL30047550 0.78 LTA4H (0.63) HRH3HRH1HRH2LTA4HTSHR
SCHEMBL28112415 0.78 CHKA (0.80) CHKACYP2D6CYP2C9TSHRSMN1; SMN2
SCHEMBL30440657 0.78 LTA4H (0.66) LTA4HALDH1A1TSHRMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed
EP-0880501-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997028128-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1997-08-07 WO disclosed